Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the contribution by the Minister of State at the Department of Health and Social Care on 12 October to the Westminster Hall debate on the Procurement of Evusheld, Official Report, column 107WH, on what date she plans to announce the accelerated timetable for the NICE assessment of Evusheld.

The National Institute for Health and Care Excellence (NICE) is conducting a Health Technology Evaluation of Evusheld. This is the routine process for new medicines to be evaluated for clinical and cost effectiveness, which will provide recommendations through NICE’s guidance on the use of Evusheld in the National Health Service. The NICE appraisal is in development and publication is expected in spring 2023.